Celeste A. Roney

Array ( [id] => 20127960 [patent_doc_number] => 12370260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Supramolecular hydrogel for lipophilic drug delivery, a preparation method therefor, and use thereof [patent_app_type] => utility [patent_app_number] => 18/718353 [patent_app_country] => US [patent_app_date] => 2022-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 13 [patent_no_of_words] => 0 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18718353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18690941 [patent_doc_number] => 20230321112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 18/078649 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18610858 [patent_doc_number] => 20230277588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING PAIN WITH EXTRACELLULAR VESICLES [patent_app_type] => utility [patent_app_number] => 18/063227 [patent_app_country] => US [patent_app_date] => 2022-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554764 [patent_doc_number] => 20240366556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => COMPOSITIONS COMPRISING PROANTHOCYANIDINS AND ZINC FOR TREATING AND/OR PREVENTING INFLAMMATION [patent_app_type] => utility [patent_app_number] => 18/579054 [patent_app_country] => US [patent_app_date] => 2022-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8897 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784076 [patent_doc_number] => 20250057755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => COMPOSITION FOR KERATIN FIBERS [patent_app_type] => utility [patent_app_number] => 18/716488 [patent_app_country] => US [patent_app_date] => 2022-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18716488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18344535 [patent_doc_number] => 20230132645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => LIPID MEMBRANE STRUCTURE FOR DELIVERY INTO SIRNA CELL [patent_app_type] => utility [patent_app_number] => 17/989260 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19170758 [patent_doc_number] => 20240156732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => Composition for Liposomal Delivery of Supplemental Creatine [patent_app_type] => utility [patent_app_number] => 17/988570 [patent_app_country] => US [patent_app_date] => 2022-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18363275 [patent_doc_number] => 20230144866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Superoxide Dismutase-Loaded Porous Polymersomes As Highly Efficient Antioxidant Nanoparticles [patent_app_type] => utility [patent_app_number] => 18/054586 [patent_app_country] => US [patent_app_date] => 2022-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19187 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18268588 [patent_doc_number] => 20230089830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => PHARMACEUTICAL PREPARATION WITH TRACING FUNCTION AND DELIVERY SYSTEM THEREFOR [patent_app_type] => utility [patent_app_number] => 18/049264 [patent_app_country] => US [patent_app_date] => 2022-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19613074 [patent_doc_number] => 20240398754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => VERATRALDEHYDE, PIPERONYL ALCOHOL, ETHYL 2-AMINO BENZOATE, ISOAMYL CINNAMATE, OR DIETHYL MALONATE AS FOOD ADDITIVES WITH ANTI-INFLAMMATORY PROPERTIES [patent_app_type] => utility [patent_app_number] => 18/698130 [patent_app_country] => US [patent_app_date] => 2022-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18698130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18672885 [patent_doc_number] => 20230310331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS [patent_app_type] => utility [patent_app_number] => 17/965880 [patent_app_country] => US [patent_app_date] => 2022-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18346447 [patent_doc_number] => 20230134557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING STEM CELL-CONDITIONED MEDIUM AND EXOSOME ISOLATED THEREFROM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCULAR DISEASE [patent_app_type] => utility [patent_app_number] => 18/046719 [patent_app_country] => US [patent_app_date] => 2022-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19629559 [patent_doc_number] => 20240408008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => AN IN-SITU GELLING ENEMA OF RIFAMYCIN FOR TREATING POUCHITIS AND DISTAL ULCERATIVE COLITIS [patent_app_type] => utility [patent_app_number] => 18/698481 [patent_app_country] => US [patent_app_date] => 2022-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18698481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18610725 [patent_doc_number] => 20230277455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES [patent_app_type] => utility [patent_app_number] => 17/960076 [patent_app_country] => US [patent_app_date] => 2022-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18193795 [patent_doc_number] => 20230047314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE [patent_app_type] => utility [patent_app_number] => 17/952300 [patent_app_country] => US [patent_app_date] => 2022-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17952300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18294388 [patent_doc_number] => 20230104074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => BORTEZOMIB COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/934873 [patent_app_country] => US [patent_app_date] => 2022-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18229893 [patent_doc_number] => 20230068887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => MODULATION OF THE NITRIC OXIDE SYNTHASE PATHWAY FOR ORAL HEALTH [patent_app_type] => utility [patent_app_number] => 17/948184 [patent_app_country] => US [patent_app_date] => 2022-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20005800 [patent_doc_number] => 20250144022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TNFAlpha ANTIBODY [patent_app_type] => utility [patent_app_number] => 18/691121 [patent_app_country] => US [patent_app_date] => 2022-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570490 [patent_doc_number] => 20240374782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => SPONGE-LIKE SCAFFOLD FOR PROMOTING HAEMOSTASIS [patent_app_type] => utility [patent_app_number] => 18/691129 [patent_app_country] => US [patent_app_date] => 2022-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18565687 [patent_doc_number] => 20230256014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHODS OF GENERATING CROSS-LINKED PROTEIN FOAMS IN SITU [patent_app_type] => utility [patent_app_number] => 17/930872 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930872 [rel_patent_id] =>[rel_patent_doc_number] =>)